genOway
ALGEN.PA
#9950
Rank
โ‚น3.31 B
Marketcap
โ‚น268.96
Share price
-2.37%
Change (1 day)
-12.32%
Change (1 year)

P/E ratio for genOway (ALGEN.PA)

P/E ratio at the end of 2024: 21.4

According to genOway's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.0714. At the end of 2024 the company had a P/E ratio of 21.4.

P/E ratio history for genOway from 2009 to 2024

PE ratio at the end of each year

Year P/E ratio Change
202421.4-16.85%
202325.8-44.65%
202246.6-140.43%
2021-115286.02%
2020-29.8296%
2019-7.54-132.26%
201823.4280.82%
20176.14-70.47%
201620.8-93.18%
2015305-27.8%
20144221256.35%
201331.1-209.37%
2012-28.5-213.13%
201125.2-3.35%
201026.0-78.61%
2009122

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.